Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of Tdap-IPV (REPEVAX) versus tetanus monovalent booster in healthy adults
2008-008724-32Phase 3Completed
- Sponsor
- Sanofi Pasteur MSD S.N.C.
- Start
- Mar 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of Adacel Polio in Tetanus (2 arms), sponsored by Sanofi Pasteur MSD S.N.C. Primary endpoint: Anti-tetanus seroprotection rate at Day 10. Started Mar 2009; status: completed.
02
Drugs
Adacel Polio
03
Conditions
Tetanus
Beyond the preview
Go deeper on 2008-008724-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008724-32.